2021
DOI: 10.3892/etm.2021.10111
|View full text |Cite
|
Sign up to set email alerts
|

Downregulation of high mobility group box 1 enhances the radiosensitivity of non‑small cell lung cancer by acting as a crucial target of microRNA‑107

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 41 publications
0
4
0
Order By: Relevance
“…24,25 For example, miR-129-5p and miR-1179 attenuated tumor proliferation via targeting HMGB1 in GC cells 26,27 miR-29b induced prostate cancer apoptosis by increasing Bim expression, 28 and miR-107 enhanced the radiosensitivity of nonsmall cell lung cancer by downregulating expression of HMGB1. 29…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…24,25 For example, miR-129-5p and miR-1179 attenuated tumor proliferation via targeting HMGB1 in GC cells 26,27 miR-29b induced prostate cancer apoptosis by increasing Bim expression, 28 and miR-107 enhanced the radiosensitivity of nonsmall cell lung cancer by downregulating expression of HMGB1. 29…”
Section: Discussionmentioning
confidence: 99%
“…24,25 For example, miR-129-5p and miR-1179 attenuated tumor proliferation via targeting HMGB1 in GC cells 26,27 miR-29b induced prostate cancer apoptosis by increasing Bim expression, 28 and miR-107 enhanced the radiosensitivity of nonsmall cell lung cancer by downregulating expression of HMGB1. 29 Extrapolating the results of the above research, we first analyzed the distribution of miRNAs in GC and adjacent normal tissues using the TCGA and TargetScan database, and then screened the differentially expressed miRNAs. We then predicted the identity of the miRNAs that possibly bind to the 3 ′ -UTRs of the HMGB1 gene using the TargetScan database (Table 1).…”
Section: Discussionmentioning
confidence: 99%
“…HMGB1 is a DNA-binding protein released during radiotherapy, and it is related to tumor radioresistance based on its DNA damage repair and autophagy functions [11]. HMGB1 is involved in mechanisms that regulate resistance to radiotherapy in pancreatic [13,14], cervical [8], breast [33], bladder [16,34], and lung cancers [15].…”
Section: Discussionmentioning
confidence: 99%
“…It is confirmed that knockdown of HMGB1 could decrease the proliferation and invasive ability of non-small cell lung cancer cells while also increasing the radiosensitivity of the cells [15]. Shrivastava et al showed a positive correlation between high levels of HMGB1 and radioresistance in bladder cancer cell lines.…”
Section: Introductionmentioning
confidence: 86%